XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Loss Per Common Share
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Loss Per Common Share Loss Per Common Share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Loss before preferred dividends and accretion of Series A Preferred Stock$(23,137)$(25,324)$(38,821)$(79,629)
Dividends and accretion of Series A Preferred Stock(8,094)(7,872)(24,018)(21,236)
Net loss attributable to common shareholders of Evolent Health, Inc.$(31,231)$(33,196)$(62,839)$(100,865)
Weighted-average common shares outstanding - basic and diluted114,862 112,282 114,565 110,464 
Loss per common share
Basic and diluted$(0.27)$(0.30)$(0.55)$(0.91)
Basic net loss per common share is calculated using the weighted average number of common shares outstanding during the period. Diluted net earnings per common share, if any, gives effect to diluted stock options (calculated based on the treasury stock method), shares issuable upon debt conversion (calculated using an as-if converted method).

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2024202320242023
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")804 1,045 782 1,311 
Stock options230 603 309 933 
Series A Preferred Stock4,375 4,375 4,375 4,375 
Convertible senior notes20,252 5,997 20,252 6,301 
Total25,661 12,020 25,718 12,920